SCHOTT Pharma AG & Co. KGaA (SHTPY)
6.55
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
SCHOTT Pharma Enterprise Value : 3.920B for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.920B |
| October 08, 2026 | 3.920B |
| October 07, 2026 | 3.920B |
| October 06, 2026 | 3.920B |
| October 05, 2026 | 3.920B |
| October 02, 2026 | 3.920B |
| October 01, 2026 | 3.920B |
| September 30, 2026 | 3.920B |
| September 29, 2026 | 3.920B |
| September 28, 2026 | 3.920B |
| September 25, 2026 | 3.920B |
| September 24, 2026 | 3.920B |
| September 23, 2026 | 3.920B |
| September 22, 2026 | 3.920B |
| September 21, 2026 | 3.920B |
| September 18, 2026 | 3.920B |
| September 17, 2026 | 3.920B |
| September 16, 2026 | 3.920B |
| September 15, 2026 | 3.920B |
| September 14, 2026 | 3.920B |
| September 11, 2026 | 4.203B |
| September 10, 2026 | 4.203B |
| September 09, 2026 | 4.203B |
| September 08, 2026 | 4.203B |
| September 04, 2026 | 4.203B |
| Date | Value |
|---|---|
| September 03, 2026 | 4.203B |
| September 02, 2026 | 4.203B |
| September 01, 2026 | 2.607B |
| August 31, 2026 | 2.607B |
| August 28, 2026 | 2.607B |
| August 27, 2026 | 2.607B |
| August 26, 2026 | 2.607B |
| August 25, 2026 | 2.607B |
| August 24, 2026 | 2.607B |
| August 21, 2026 | 2.607B |
| August 20, 2026 | 2.607B |
| August 19, 2026 | 2.607B |
| August 18, 2026 | 2.607B |
| August 17, 2026 | 2.607B |
| August 14, 2026 | 2.607B |
| August 13, 2026 | 2.607B |
| August 12, 2026 | 2.607B |
| August 11, 2026 | 2.607B |
| August 10, 2026 | 2.607B |
| August 07, 2026 | 2.607B |
| August 06, 2026 | 2.607B |
| August 05, 2026 | 2.607B |
| August 04, 2026 | 2.607B |
| August 03, 2026 | 2.607B |
| July 31, 2026 | 2.607B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services, Inc. | 25.65B |
| Drägerwerk AG & Co. KGaA | 2.138B |
| Sartorius AG | 15.66B |
| Reflect Scientific, Inc. | 3.273M |
| Ottobock SE & Co. KGaA | 5.309B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 45.32M |
| Revenue (Quarterly) | 327.61M |
| Total Expenses (Quarterly) | 282.46M |
| EPS Diluted (Quarterly) | 0.0749 |
| Gross Profit Margin (Quarterly) | 30.66% |
| Profit Margin (Quarterly) | 13.83% |
| Earnings Yield | 4.04% |
| Operating Earnings Yield | 4.66% |
| Normalized Earnings Yield | 4.037 |